Search General Info

Seiji Hirasaki

Tokyo, Japan
He co-founded OriCiro Genomics in December 2018 and has served as the CEO since then. Prior to founding OriCiro, he was the COO of AnGes, a gene therapy company based in Tokyo, where he worked for sixteen years with escalating responsibilities in business and corporate development functions. Previously, he was a journalist with NIKKEI, a leading economic newspaper in Japan, covering biotechnology, medicine and science policy. He received his MSc in physics from Tohoku University, Japan, and another MSc in science and technology policy from University of Sussex, UK.
Speaking In
[Available On-Demand]
OriCiro Genomics is a cell-free genome technology company. The company offers the next-generation…
Click video to start playback; Join chat Q&A below video